Atara Biotherapeutics, Inc. (ATRA)
Market Closed
17 Jul, 20:00
$
8. 39
-0.33
-3.7844%
$
87.94M Market Cap
- P/E Ratio
- Div Yield
81,300 Volume
-2.6 Eps
$ 8.72
Previous Close Investors:
Want to track ATRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 3.5 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ATRA Earnings Reports FAQ
What is the earnings per share (EPS) for ATRA?
The current EPS is -2.6.
What is the company's earnings growth rate?
Atara Biotherapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Atara Biotherapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Atara Biotherapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ATRA at this time, as Atara Biotherapeutics, Inc has no recent EPS data to calculate it.
